Does inflammation influence atrial fibrillation recurrence following catheter ablation?

Europace

Volumn 11, Issue 2, 2009, Pages 135-137

  Kourliouros, Antonios ^a   Camm, A John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LYSOPHOSPHOLIPID;

CARDIOPULMONARY BYPASS; CARDIOVERSION; CATHETER ABLATION; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART SURGERY; HUMAN; INFLAMMATION; PHAGOCYTOSIS; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROTEIN BINDING; PULMONARY VEIN;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CATHETER ABLATION; HEART ATRIA; HUMANS; HYPERTENSION; INFLAMMATION; LEUKOCYTE COUNT; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK FACTORS;

EID: 59449097419     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun386     Document Type: Editorial

References (20)

1. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10.
2. Conway DS, Buggins P, Hughes E, Lip GY. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol 2004;94:508-10.
3. Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001;56:375-80.
4. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-8.
5. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-91.
6. Savelieva I, Camm J. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation. Nat Clin Pract Cardiovasc Med 2008;5:30-41.
7. Jahangiri M, Camm AJ. Do corticosteroids prevent atrial fibrillation after cardiac surgery? Nat Clin Pract Cardiovasc Med 2007;4:592-3.
8. Hack CE, Wolbink GJ, Schalkwijk C, Speijer H, Hermens WT, van den Bosch H. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today 1997;18:111-5.
9. Aime-Sempe C, Folliguet T, Rucker-Martin C, Krajewska M, Krajewska S, Heimburger M et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 1999;34:1577-86.
10. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-26.
11. Pogwizd SM, Onufer JR, Kramer JB, Sobel BE, Corr PB. Induction of delayed afterdepolarizations and triggered activity in canine Purkinje fibers by lysophosphoglycerides. Circ Res 1986;59:416-26.
12. Tselentakis EV, Woodford E, Chandy J, Gaudette GR, Saltman AE. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res 2006;135:68-75.
13. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007;49:1642-8.
14. Sata N, Hamada N, Horinouchi T, Amitani S, Yamashita T, Moriyama Y et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J 2004;45:441-5.
15. Letsas K, Weber R, Bürkle G, Mihas CC, Minners J, Kalusche D et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace 2009;11:158-163.
16. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ et al. HRS/EHRA/ ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007;9:335-79.
17. Marcus GM, Smith LM, Glidden DV, Wilson E, McCabe JM, Whiteman D et al. Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm 2008;5:215-21.
18. Liuba I, Ahlmroth H, Jonasson L, Englund A, Jonsson A, Safstrom K et al. Source of inflammatory markers in patients with atrial fibrillation. Europace 2008;10:848-53.
19. McCabe JM, Smith LM, Tseng ZH, Badhwar N, Lee BK, Lee RJ et al. Protracted CRP elevation after atrial fibrillation ablation. Pacing Clin Electrophysiol 2008;31:1146-51.
20. Stein A, Wessling G, Deisenhofer I, Busch G, Steppich B, Estner H et al. Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization. Europace 2008;10:444-9.